Missed Opportunities for HIV Screening in General Practice

Missed Opportunities for HIV Screening in General Practice - A Retrospective Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07303114

Acronym

DepVIH

Enrollment

Registered

2025-12-24

Start date

2025-04-14

Completion date

2026-07-31

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV infections, HIV Testing

Brief summary

The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult subject (≥18 years) * diagnosed with HIV infection between January 1, 2021, and July 30, 2024

Exclusion criteria

-Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.

Design outcomes

Primary

Measure	Time frame	Description
Presence or absence of clinical signs suggestive of HIV infection	1 year preceding HIV diagnosis	This is a retrospective analysis of data on the presence or absence of clinical signs suggestive of HIV infection during the year preceding diagnosis

Countries

France

Contacts

Primary Contactbaptiste Hoellinger, MD

baptiste.hoellinger@chru-strasbourg.fr33 3 69 55 05 45

Outcome results